Cargando…
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697690/ https://www.ncbi.nlm.nih.gov/pubmed/27885772 http://dx.doi.org/10.1111/1471-0528.14400 |
_version_ | 1783280667480555520 |
---|---|
author | Long, Q Oladapo, OT Leathersich, S Vogel, JP Carroli, G Lumbiganon, P Qureshi, Z Gülmezoglu, AM |
author_facet | Long, Q Oladapo, OT Leathersich, S Vogel, JP Carroli, G Lumbiganon, P Qureshi, Z Gülmezoglu, AM |
author_sort | Long, Q |
collection | PubMed |
description | OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper‐based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO (4); availability of a formal clinical protocol for MgSO (4) administration; and MgSO (4) dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO (4) was used for the treatment of mild pre‐eclampsia, severe pre‐eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre‐eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO (4) for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO (4) regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations. |
format | Online Article Text |
id | pubmed-5697690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56976902017-11-28 Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey Long, Q Oladapo, OT Leathersich, S Vogel, JP Carroli, G Lumbiganon, P Qureshi, Z Gülmezoglu, AM BJOG General Obstetrics OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper‐based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO (4); availability of a formal clinical protocol for MgSO (4) administration; and MgSO (4) dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO (4) was used for the treatment of mild pre‐eclampsia, severe pre‐eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre‐eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO (4) for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO (4) regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations. John Wiley and Sons Inc. 2016-11-24 2017-11 /pmc/articles/PMC5697690/ /pubmed/27885772 http://dx.doi.org/10.1111/1471-0528.14400 Text en © 2016 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | General Obstetrics Long, Q Oladapo, OT Leathersich, S Vogel, JP Carroli, G Lumbiganon, P Qureshi, Z Gülmezoglu, AM Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title | Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title_full | Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title_fullStr | Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title_full_unstemmed | Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title_short | Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
title_sort | clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey |
topic | General Obstetrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697690/ https://www.ncbi.nlm.nih.gov/pubmed/27885772 http://dx.doi.org/10.1111/1471-0528.14400 |
work_keys_str_mv | AT longq clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT oladapoot clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT leathersichs clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT vogeljp clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT carrolig clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT lumbiganonp clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT qureshiz clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT gulmezogluam clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey AT clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey |